The success of revascularization procedures is limited by recurrent stenosis, which is a narrowing of a blood vessels that results from neo-intimal hyperplasia. The renin-angiotensin-aldosterone system has been implicated in the pathogenesis of neo-intimal hyperplasia, and a role for angiotensin II in vascular smooth muscle cell proliferation has been proposed. There are at least two high-affinity subtypes of angiotensin II receptors, AT1 and AT2, both of which are seven-transmembrane G protein-coupled receptors. We investigated the effect of losartan, an AT1 receptor antagonist, on vascular smooth muscle cell proliferation using the A7r5 smooth cell line derived from rat aorta. Losartan was shown to prevent angiotensin II-induced cell prol...
The in vitro effects of angiotensin II (Ang II) in human vessels are not well studied. The developme...
Angiotensin (Ang) II and Ang-(1-7) are two of the bioactive peptides of the rennin-angiotensin syste...
Abstract—We investigated the ability of angiotensin II type 1 (AT1) receptor blockers with peroxisom...
The success of revascularization procedures is limited by recurrent stenosis, which is a narrowing o...
Angiotensin type 2 (AT(2)) receptors for angiotensin II suppress cell growth and induce apoptosis in...
Angiotensin II is a vasoactive peptide and may act as a growth factor in vascular smooth muscle cell...
1 We recently demonstrated that intracellular application of Angiotensin II (Angiotensin IIintr) ind...
1 We recently demonstrated that intracellular application of Angiotensin II (Angiotensin IIintr) ind...
1 We recently demonstrated that intracellular application of Angiotensin II (Angiotensin IIintr) ind...
Angiotensin II may be an important mediator of neointima formation in vascular disease. This study w...
Angiotensin II may be an important mediator of neointima formation in vascular disease. This study w...
Angiotensin II may be an important mediator of neointima formation in vascular disease. This study w...
Angiotensin II may be an important mediator of neointima formation in vascular disease. This study w...
Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle c...
Angiotensin II is an important modulator of cell growth through AT(1) receptors, as demonstrated bot...
The in vitro effects of angiotensin II (Ang II) in human vessels are not well studied. The developme...
Angiotensin (Ang) II and Ang-(1-7) are two of the bioactive peptides of the rennin-angiotensin syste...
Abstract—We investigated the ability of angiotensin II type 1 (AT1) receptor blockers with peroxisom...
The success of revascularization procedures is limited by recurrent stenosis, which is a narrowing o...
Angiotensin type 2 (AT(2)) receptors for angiotensin II suppress cell growth and induce apoptosis in...
Angiotensin II is a vasoactive peptide and may act as a growth factor in vascular smooth muscle cell...
1 We recently demonstrated that intracellular application of Angiotensin II (Angiotensin IIintr) ind...
1 We recently demonstrated that intracellular application of Angiotensin II (Angiotensin IIintr) ind...
1 We recently demonstrated that intracellular application of Angiotensin II (Angiotensin IIintr) ind...
Angiotensin II may be an important mediator of neointima formation in vascular disease. This study w...
Angiotensin II may be an important mediator of neointima formation in vascular disease. This study w...
Angiotensin II may be an important mediator of neointima formation in vascular disease. This study w...
Angiotensin II may be an important mediator of neointima formation in vascular disease. This study w...
Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle c...
Angiotensin II is an important modulator of cell growth through AT(1) receptors, as demonstrated bot...
The in vitro effects of angiotensin II (Ang II) in human vessels are not well studied. The developme...
Angiotensin (Ang) II and Ang-(1-7) are two of the bioactive peptides of the rennin-angiotensin syste...
Abstract—We investigated the ability of angiotensin II type 1 (AT1) receptor blockers with peroxisom...